SCHEMBL7053928

SCHEMBL7053928

CNCCI

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL28658437 0.96
Iodide SCHEMBL28654692 0.96
Bromide SCHEMBL28667693 0.96
Sulfuric Acid SCHEMBL28672831 0.82 CA5A (0.33)
SCHEMBL18054741 0.79
SCHEMBL295853 0.77
SCHEMBL13634251 0.74
Hydrochloric Acid SCHEMBL19922518 0.74
SCHEMBL9882703 0.74
SCHEMBL16303452 0.73 EPHX1 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113563255-B Preparation method of remifloxacin intermediate 成都倍特药业股份有限公司 2023-08-18 CN claimed
CN-113563255-A Preparation method of Rifloxacin intermediate 成都倍特药业股份有限公司 2021-10-29 CN claimed
CN-113563255-B Preparation method of remifloxacin intermediate 成都倍特药业股份有限公司 2023-08-18 CN disclosed
CN-113563255-A Preparation method of Rifloxacin intermediate 成都倍特药业股份有限公司 2021-10-29 CN disclosed
EP-2438078-B1 NOVOBIOCIN ANALOGUES HAVING MODIFIED SUGAR MOIETIES UNIV KANSAS (US) 2017-10-25 EP disclosed
WO-2017153601-A1 BICYCLIC COMPOUNDS FOR DIAGNOSIS AND THERAPY AC IMMUNE SA (CH) 2017-09-14 WO disclosed
US-9744183-B2 Nucleic acid prodrugs and methods of use thereof WAVE LIFE SCIENCES LTD. (SG) 2017-08-29 US disclosed
WO-2016164675-A1 SUBSTITUTED QUINAZOLINE COMPOUNDS AND METHODS OF USE THEREOF ARAXES PHARMA LLC (US) 2016-10-13 WO disclosed
WO-2015195228-A1 HETEROARYL COMPOUNDS FOR KINASE INHIBITION ARIAD PHARMACEUTICALS, INC. (US) 2015-12-23 WO disclosed
US-9051500-B2 Compositions comprising 2,3,3,3-tetrafluoropropene, 1,1,2,3-tetra-chloropropene, 2-chloro-3,3,3-trifluoropropene, or 2-chloro-1,1,1,2-tetrafluoropropane E I DU PONT DE NEMOURS AND COMPANY (US) 2015-06-09 US disclosed
US-8284142-B2 Display device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-10-09 US disclosed
US-20100009975-A1 BENZOXAZINES, BENZOTHIAZINES, AND RELATED COMPOUNDS HAVING NOS INHIBITORY ACTIVITY NEURAXON, INC. (CA) 2010-01-14 US disclosed
EP-0882715-B1 NOVEL N-(UNSUBSTITUTED OR SUBSTITUTED)-4-SUBSTITUTED-6-(UNSUBSTITUTED OR SUBSTITUTED)PHENOXY-2-PYRIDINECARBOXAMIDES OR THIOCARBOXAMIDES, PROCESSES FOR PRODUCING THE SAME, AND HERBICIDES KUREHA CHEMICAL IND CO LTD (JP) 2003-04-23 EP disclosed
US-6339045-B1 CAN BE USED IN A SMALL AMOUNT, SHOWING A GOOD SELECTIVITY BETWEEN CROP AND WEED, AND CAUSING NO PHYTOTOXICITY KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) 2002-01-15 US disclosed
CN-1055924-C Novel aminoalkyl benzoxazolinones and benzothiazolinones process for their preparation and the pharmaceutical compositions which contain them ADIR (FR) 2000-08-30 CN disclosed
EP-0882715-A1 NOVEL N-(UNSUBSTITUTED OR SUBSTITUTED)-4-SUBSTITUTED-6-(UNSUBSTITUTED OR SUBSTITUTED)PHENOXY-2-PYRIDINECARBOXAMIDES OR THIOCARBOXAMIDES, PROCESSES FOR PRODUCING THE SAME, AND HERBICIDES KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) 1998-12-09 EP disclosed
EP-0605582-A1 PHOSPHORAMIDATE ANALOGS OF 5-FLUORO-2'-DEOXYURIDINE THE UNIVERSITY OF ROCHESTER (US) 1994-07-13 EP disclosed
US-5233031-A Antitumor, anticarcinogenic agents UNIVERSITY OF ROCHESTER (US) 1993-08-03 US disclosed
WO-1993006120-A1 PHOSPHORAMIDATE ANALOGS OF 5-FLUORO-2'-DEOXYURIDINE UNIVERSITY OF ROCHESTER (US) 1993-04-01 WO disclosed
US-4167623-A Pullulan aminoalkyl ether SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1979-09-11 US disclosed